22 Apr 2026
RAAHS Prescription Rules Updated to Improve Accuracy and Avoid Delays
A recent review of Remote Area Aboriginal Health Services (RAAHS) prescriptions has found that some important details are often missing.
17 Apr 2026
Multiple Myeloma Meeting Outcome Statement Released (Feb 2026)
Multiple Myeloma Meeting Outcome Statement Released (Feb 2026)
08 Apr 2026
Lamotrigine Recommended for PBS Listing in Bipolar Treatment
The Pharmaceutical Benefits Advisory Committee has recommended adding lamotrigine to the Pharmaceutical Benefits Scheme as a restricted benefit for treating bipolar disorder.
07 Apr 2026
PBAC Update – March 2026
The latest update from the Pharmaceutical Benefits Advisory Committee following its March 2026 meeting is now available on the Pharmaceutical Benefits Scheme website.
01 Apr 2026
PBS Update: Macrogol 3350 Access Changes from 1 April 2026
From 1 April 2026, the PBS has updated the access rules for macrogol 3350 (sachets 13.125 g with electrolytes, 30) and its listed brands.
01 Apr 2026
PBS Update: Easier Access to Combination Blood Pressure Medicines
From 1 April 2026, changes to the Pharmaceutical Benefits Scheme (PBS) make it easier for Australians to access fixed-dose combination (FDC) medicines to treat high blood pressure.
25 Mar 2026
Have Your Say on New Medicines – PBAC Meeting July 2026
The agenda for the Pharmaceutical Benefits Advisory Committee (PBAC) meeting in July 2026 is now available.
01 Mar 2026
PBS Broadens Nivolumab and Ipilimumab Access from 1 March 2026
From 1 March 2026, the PBS will expand listings for nivolumab and ipilimumab, allowing wider use for patients with advanced or metastatic cancers.
12 Feb 2026
New Medicines and Vaccines Under Review by PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) has published its latest meeting agenda, outlining which medicines and vaccines are being considered for listing or changes under the Pharmaceutical Benefits Scheme (PBS) and the National Immunisation Program (NIP).